Abstract We investigated rates and controls on greenhouse gas (CO 2 and CH 4 ) production in two contrasting water‐saturated tundra soils within a permafrost‐affected watershed near Nome, Alaska, United States. Three years of field sample analysis have shown that soil from a fen‐like area in the toeslope of the watershed had higher pH and higher porewater ion concentrations than soil collected from a bog‐like peat plateau at the top of the hillslope. The influence of these contrasting geochemical and topographic environments on CO 2 and CH 4 production was tested in soil microcosms by incubating both the organic‐ and mineral‐layer soils anaerobically for 55 days. Nitrogen (as NH 4 Cl) was added to half of the microcosms to test potential effects of N limitation on microbial greenhouse gas production. We found that the organic toeslope soils produced more CO 2 and CH 4 , fueled by higher pH and higher concentrations of water‐extractable organic C (WEOC). Our results also indicate N limitation on CO 2 production in the peat plateau soils but not the toeslope soils. Together these results suggest that the weathering and leaching of ions and nutrients from tundra hillslopes can increase the rate of anaerobic soil organic matter decomposition in downslope soils by (1) increasing the pH of soil porewater; (2) providing bioavailable WEOC and fermentation products such as acetate; and (3) relieving microbial N limitation through nutrient runoff. We conclude that the soil geochemistry as mediated by landscape position is an important factor influencing the rate and magnitude of greenhouse gas production in tundra soils.
The dissolution of metal sulfides, such as ZnS, is an important biogeochemical process affecting fate and transport of trace metals in the environment. However, current studies of in situ dissolution of metal sulfides and the effects of structural defects on dissolution are lacking. Here we have examined the dissolution behavior of ZnS nanoparticles synthesized via several abiotic and biological pathways. Specifically, we have examined biogenic ZnS nanoparticles produced by an anaerobic, metal-reducing bacterium Thermoanaerobacter sp. X513 in a Zn-amended, thiosulfate-containing growth medium in the presence or absence of silver (Ag), and abiogenic ZnS nanoparticles were produced by mixing an aqueous Zn solution with either H2S-rich gas or Na2S solution. The size distribution, crystal structure, aggregation behavior, and internal defects of the synthesized ZnS nanoparticles were examined using high-resolution transmission electron microscopy (TEM) coupled with X-ray energy dispersive spectroscopy. The characterization results show that both the biogenic and abiogenic samples were dominantly composed of sphalerite. In the absence of Ag, the biogenic ZnS nanoparticles were significantly larger (i.e., ∼10 nm) than the abiogenic ones (i.e., ∼3–5 nm) and contained structural defects (e.g., twins and stacking faults). The presence of trace Ag showed a restraining effect on the particle size of the biogenic ZnS, resulting in quantum-dot-sized nanoparticles (i.e., ∼3 nm). In situ dissolution experiments for the synthesized ZnS were conducted with a liquid-cell TEM (LCTEM), and the primary factors (i.e., the presence or absence structural defects) were evaluated for their effects on the dissolution behavior using the biogenic and abiogenic ZnS nanoparticle samples with the largest average particle size. Analysis of the dissolution results (i.e., change in particle radius with time) using the Kelvin equation shows that the defect-bearing biogenic ZnS nanoparticles (γ = 0.799 J/m2) have a significantly higher surface energy than the abiogenic ZnS nanoparticles (γ = 0.277 J/m2). Larger defect-bearing biogenic ZnS nanoparticles were thus more reactive than the smaller quantum-dot-sized ZnS nanoparticles. These findings provide new insight into the factors that affect the dissolution of metal sulfide nanoparticles in relevant natural and engineered scenarios, and have important implications for tracking the fate and transport of sulfide nanoparticles and associated metal ions in the environment. Moreover, our study exemplified the use of an in situ method (i.e., LCTEM) to investigate nanoparticle behavior (e.g., dissolution) in aqueous solutions.
Adsorbed or solid-phase inorganic mercury [Hg(II)] is commonly assumed immobile or less bioavailable for microbial uptake, although recent studies suggest that mineral-adsorbed Hg(II) is at least partially available for cell uptake and methylation. This study examined the adsorption of Hg(II) onto two reference minerals, hematite and montmorillonite, and evaluated Hg(II) uptake and methylation by a sulfate-reducing bacterium Desulfovibrio desulfuricans ND132 in laboratory incubations. Mineral-adsorbed Hg(II) on both hematite and montmorillonite was not only available for cell uptake and methylation but also resulted in a 2–3-fold increased methylmercury production compared to the mineral-free incubation. An optimal Hg(II) methylation was observed at a low to moderate mineral/solution ratio (1–5 g L–1) with fixed Hg(II) (25 nM) and cell concentrations. The result could be explained by decreased cellular immobilization of Hg(II) but enhanced close interactions between Hg(II) and cells both adsorbed or concentrated on mineral surfaces, leading to increased methylation. However, a high mineral/solution ratio inhibited Hg(II) methylation, likely as a result of a low Hg(II) coverage (per surface area) at high mineral loadings, which limit close contacts between Hg(II) and the cells. These results indicate that mineral-adsorbed Hg(II) may be directly available for microbial uptake or methylation, although whether the adsorption enhances or inhibits Hg(II) methylation may depend upon microniches, where Hg(II), microbes, and minerals co-exist in the natural environment. We suggest that future studies are performed to establish quantitative relationships of bioavailable Hg(II) with not only the dissolved but also adsorbed Hg(II) species to improve model predictions of Hg(II) fate and transformations.
ABSTRACT The high levels of hepatitis B virus (HBV) surface antigen (HBsAg)-bearing subviral particles in the serum of chronically infected individuals are thought to play a role in suppressing the HBV-specific immune response. Current therapeutics are not directed at reducing this viral antigenemia; thus, our group has focused on identifying inhibitors of HBsAg secretion. By using the HBV-expressing cell line HepG2.2.15, high-throughput screening of an 80,288-compound synthetic small-molecule library identified HBF-0259, an aromatically substituted tetrahydro-tetrazolo-(1, 5- a )-pyrimidine. Following resynthesis, HBF-0259 had a 50% effective concentration of approximately 1.5 μM in a secondary, HBV-expressing cell line, with a concentration that exhibited 50% cytotoxicity of >50 μM. The equilibrium concentration of HBF-0259 in aqueous solution at physiological pH was 15 to 16 μM; the selective index was thus >9. As intended by our screening paradigm, HBF-0259 is a selective, potent inhibitor of secretion of both subviral and DNA-containing viral particles, while the secretion of α-1-acid glycoprotein and α-1-antitrypsin was unaffected. The HBV e antigen, which is not a constituent of HBV particles, was also unaffected, suggesting that the secretion of particles bearing HBV structural glycoproteins is targeted directly. Inhibitory activity was also confirmed by transfection of HBsAg, indicating that the action of the compound is independent of those of other viral proteins. HBF-0259 had no effect on HBV DNA synthesis, demonstrating that inhibition is independent of viral genomic replication. Finally, HBF-0259 had little or no effect on the cell-to-cell spread of two unrelated viruses, suggesting that it is a specific inhibitor of secretion of HBsAg. Possible mechanisms of action and the implications for its development are discussed.